Title
Serum 17-α-hydroxyprogesterone, progesterone, estradiol, and testosterone in the diagnosis and management of congenital adrenal hyperplasia
Date Issued
01 January 1974
Access level
metadata only access
Resource Type
journal article
Author(s)
Lippe B.
LaFranchi S.
Lavin N.
Parlow A.
Kaplan S.
Abstract
The value of determining concentrations of serum 17-α-hydroxyprogesterone, progesterone, estradiol, and testosterone in the diagnosis and management of congenital adrenal hyperplasia was studied. The values recorded were compared with established criteria of control: growth rate, advancement of bone age, degree of virilization, and 24-hour urine excretion of 17-ketosteroids and pregnanetriol. Serum 17-OHP concentrations were diagnostic in five new patients with CAH; they ranged from 100-312 ng/ml (50 to 450-fold above normal); serum progesterone concentrations ranged from 7-24 ng/ml (2 to 50-fold above normal). In the long-term management no one serum steroid concentration alone could be relied upon to determine adequacy of control. It appears that several variables, including diurnal variation, timing of the sample in relation to the last dose of a glucocorticoid, and chronic suppression of the hypothalamic-pituitary-adrenal axis, in addition to the degree of control, may affect a single serum steroid determination. When an acceptable range of normal in CAH for concentration of serum 17-OPH was broadened to 4 ng/ml and for progesterone to 1 ng/ml, there was a fairly good correlation of serum steroid concentrations with degree of control. © 1974 The C. V. Mosby Company.
Start page
782
End page
787
Volume
85
Issue
6
Language
English
OCDE Knowledge area
Ciencias médicas, Ciencias de la salud Endocrinología, Metabolismo (incluyendo diabetes, hormonas)
Scopus EID
2-s2.0-0016277757
PubMed ID
Source
The Journal of Pediatrics
ISSN of the container
00223476
Sponsor(s)
March Computing assistance was obtained from the Health Sciences Computing Facility, UCLA, sponsored by the National Institutes of Health Special Research Resources Grant RR Supported in part by United States Public Health Service Grants No. RR865 andAM11214
Sources of information: Directorio de Producción Científica Scopus